afdos pharmaceuticals limited
afdos pharmaceuticals limited Company Information
Company Number
09328114
Website
www.afdospharmaceuticals.comRegistered Address
6 maida vale business centre, mead road, cheltenham, gloucestershire, GL53 7ER
Industry
Wholesale of pharmaceutical goods
Telephone
-
Next Accounts Due
September 2025
Group Structure
View All
Directors
Peter Hulett9 Years
Shareholders
maurice edgington 38%
peter guy hulett 38%
View Allafdos pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AFDOS PHARMACEUTICALS LIMITED at £282.8k based on a Turnover of £630.9k and 0.45x industry multiple (adjusted for size and gross margin).
afdos pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AFDOS PHARMACEUTICALS LIMITED at £0 based on an EBITDA of £-12.4k and a 3.25x industry multiple (adjusted for size and gross margin).
afdos pharmaceuticals limited Estimated Valuation
Pomanda estimates the enterprise value of AFDOS PHARMACEUTICALS LIMITED at £217.1k based on Net Assets of £105.3k and 2.06x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Afdos Pharmaceuticals Limited Overview
Afdos Pharmaceuticals Limited is a live company located in cheltenham, GL53 7ER with a Companies House number of 09328114. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in November 2014, it's largest shareholder is maurice edgington with a 38% stake. Afdos Pharmaceuticals Limited is a established, small sized company, Pomanda has estimated its turnover at £630.9k with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Afdos Pharmaceuticals Limited Health Check
Pomanda's financial health check has awarded Afdos Pharmaceuticals Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
6 Weak
Size
annual sales of £630.9k, make it smaller than the average company (£25.6m)
- Afdos Pharmaceuticals Limited
£25.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 28%, show it is growing at a faster rate (5.1%)
- Afdos Pharmaceuticals Limited
5.1% - Industry AVG
Production
with a gross margin of 14.5%, this company has a higher cost of product (26.2%)
- Afdos Pharmaceuticals Limited
26.2% - Industry AVG
Profitability
an operating margin of -2% make it less profitable than the average company (3.9%)
- Afdos Pharmaceuticals Limited
3.9% - Industry AVG
Employees
with 1 employees, this is below the industry average (42)
- Afdos Pharmaceuticals Limited
42 - Industry AVG
Pay Structure
on an average salary of £76.9k, the company has an equivalent pay structure (£76.9k)
- Afdos Pharmaceuticals Limited
£76.9k - Industry AVG
Efficiency
resulting in sales per employee of £630.9k, this is equally as efficient (£701.4k)
- Afdos Pharmaceuticals Limited
£701.4k - Industry AVG
Debtor Days
it gets paid by customers after 134 days, this is later than average (60 days)
- Afdos Pharmaceuticals Limited
60 days - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (29 days)
- Afdos Pharmaceuticals Limited
29 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Afdos Pharmaceuticals Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Afdos Pharmaceuticals Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 54.9%, this is a similar level of debt than the average (54.6%)
54.9% - Afdos Pharmaceuticals Limited
54.6% - Industry AVG
AFDOS PHARMACEUTICALS LIMITED financials
Afdos Pharmaceuticals Limited's latest turnover from December 2023 is estimated at £630.9 thousand and the company has net assets of £105.3 thousand. According to their latest financial statements, we estimate that Afdos Pharmaceuticals Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | |||||||||
| Tax | |||||||||
| Profit After Tax | |||||||||
| Dividends Paid | |||||||||
| Retained Profit | |||||||||
| Employee Costs | |||||||||
| Number Of Employees | 2 | 2 | 2 | 1 | 1 | 1 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 1,024 | 1,328 | 1,630 | 1,754 | 525 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 7,840 | 233,024 | 31,414 | 31,414 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 205,000 | 180,000 | 120,000 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 205,000 | 181,024 | 121,328 | 9,470 | 234,778 | 31,939 | 31,414 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 53,449 | 0 | 0 | 0 |
| Trade Debtors | 232,617 | 256,009 | 0 | 0 | 20,349 | 32,643 | 41,015 | 177,764 | 13,542 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 895 | 5,359 | 5,317 | 1,275 | 93,334 | 224,252 | 184,189 | 5,614 | 120 |
| Cash | 0 | 0 | 102,741 | 18,389 | 3,723 | 110,055 | 303,504 | 109,416 | 206,912 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 233,512 | 261,368 | 108,058 | 19,664 | 117,406 | 420,399 | 528,708 | 292,794 | 220,574 |
| total assets | 233,512 | 261,368 | 313,058 | 200,688 | 238,734 | 429,869 | 763,486 | 324,733 | 251,988 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 550 | 10,601 | 551 | 1,290 | 5,433 | 75,575 | 2,862 | 24,120 | 415 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 11,973 | 3,329 | 7,055 | 28,359 | 396,809 | 15,030 | 3,954 |
| total current liabilities | 550 | 10,601 | 12,524 | 4,619 | 12,488 | 103,934 | 399,671 | 39,150 | 4,369 |
| loans | 0 | 0 | 35,000 | 50,000 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 360 | 750 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 127,280 | 132,280 | 138,280 | 6,520 | 91,335 | 159,644 | 100,000 | 277,477 | 283,320 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 127,640 | 133,030 | 173,280 | 56,520 | 91,335 | 159,644 | 100,000 | 277,477 | 283,320 |
| total liabilities | 128,190 | 143,631 | 185,804 | 61,139 | 103,823 | 263,578 | 499,671 | 316,627 | 287,689 |
| net assets | 105,322 | 117,737 | 127,254 | 139,549 | 134,911 | 166,291 | 263,815 | 8,106 | -35,701 |
| total shareholders funds | 105,322 | 117,737 | 127,254 | 139,549 | 134,911 | 166,291 | 263,815 | 8,106 | -35,701 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | 0 | 0 | 201 | 304 | 302 | 302 | 95 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 3,900 | 63,400 | 0 | |
| Tax | |||||||||
| Stock | 0 | 0 | 0 | 0 | -53,449 | 53,449 | 0 | 0 | 0 |
| Debtors | -27,856 | 51,051 | 29,042 | -52,408 | -23,212 | 31,691 | 41,826 | 169,716 | 13,662 |
| Creditors | -10,051 | 10,050 | -739 | -4,143 | -70,142 | 72,713 | -21,258 | 23,705 | 415 |
| Accruals and Deferred Income | -390 | -11,223 | 8,644 | -3,726 | -21,304 | -368,450 | 381,779 | 11,076 | 3,954 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | -35,000 | -15,000 | 50,000 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | -5,000 | -6,000 | 131,760 | -84,815 | -68,309 | 59,644 | -177,477 | -5,843 | 283,320 |
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | |||||||||
| cash and cash equivalents | |||||||||
| cash | 0 | -102,741 | 84,352 | 14,666 | -106,332 | -193,449 | 194,088 | -97,496 | 206,912 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | -102,741 | 84,352 | 14,666 | -106,332 | -193,449 | 194,088 | -97,496 | 206,912 |
afdos pharmaceuticals limited Credit Report and Business Information
Afdos Pharmaceuticals Limited Competitor Analysis
Perform a competitor analysis for afdos pharmaceuticals limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in GL53 area or any other competitors across 12 key performance metrics.
afdos pharmaceuticals limited Ownership
AFDOS PHARMACEUTICALS LIMITED group structure
Afdos Pharmaceuticals Limited has no subsidiary companies.
Ultimate parent company
AFDOS PHARMACEUTICALS LIMITED
09328114
afdos pharmaceuticals limited directors
Afdos Pharmaceuticals Limited currently has 1 director, Mr Peter Hulett serving since Nov 2014.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Peter Hulett | United Kingdom | 59 years | Nov 2014 | - | Director |
P&L
December 2023turnover
630.9k
-10%
operating profit
-12.4k
0%
gross margin
14.5%
+1.52%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
105.3k
-0.11%
total assets
233.5k
-0.11%
cash
0
0%
net assets
Total assets minus all liabilities
afdos pharmaceuticals limited company details
company number
09328114
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
November 2014
age
10
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
afdos limited (April 2016)
last accounts submitted
December 2023
address
6 maida vale business centre, mead road, cheltenham, gloucestershire, GL53 7ER
accountant
BENTLEY FINANCIAL SOLUTIONS
auditor
-
afdos pharmaceuticals limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to afdos pharmaceuticals limited.
afdos pharmaceuticals limited Companies House Filings - See Documents
| date | description | view/download |
|---|
